Predictive Oncology Stock Investor Sentiment
| POAI Stock | USD 0.96 0.03 3.03% |
Under 51% of Predictive Oncology's traders are presently thinking to get in. The analysis of overall sentiment of trading Predictive Oncology stock suggests that some investors are interested at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Comfort Level 51
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Predictive Oncology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Predictive Oncology.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Predictive Historical Sentiment
Although Predictive Oncology's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Predictive, such as negative comments on social media and news outlets, may cause fear in the market and push Predictive Oncology's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Predictive.
Predictive | Build AI portfolio with Predictive Stock |
Predictive Oncology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Predictive Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Predictive Oncology Historical Investor Sentiment
Investor biases related to Predictive Oncology's public news can be used to forecast risks associated with an investment in Predictive. The trend in average sentiment can be used to explain how an investor holding Predictive can time the market purely based on public headlines and social activities around Predictive Oncology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Predictive Oncology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Predictive Oncology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Predictive Oncology news discussions. The higher the estimate score, the more favorable the investor's outlook on Predictive Oncology.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Predictive Oncology's Stock prices. Below is the latest headlines and news related to Predictive Oncology Stock. Current markets are strongly bearish. About 79% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Predictive Oncology that are available to investors today. This information is accessible both publicly - through Predictive Oncology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Predictive-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Predictive Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Predictive Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Predictive Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Predictive Oncology alpha.
Predictive Largest EPS Surprises
Earnings surprises can significantly impact Predictive Oncology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-12 | 2022-03-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2021-08-11 | 2021-06-30 | -0.07 | -0.05 | 0.02 | 28 | ||
2021-05-12 | 2021-03-31 | -0.09 | -0.11 | -0.02 | 22 | ||
2021-11-10 | 2021-09-30 | -0.05 | -0.08 | -0.03 | 60 | ||
2023-03-21 | 2022-12-31 | -0.06 | -0.1 | -0.04 | 66 | ||
2022-11-10 | 2022-09-30 | -0.01 | -0.05 | -0.04 | 400 |
There is far too much social signal, news, headlines, and media speculation about Predictive Oncology that are available to investors today. This information is accessible both publicly - through Predictive Oncology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Predictive-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Predictive Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Predictive Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Predictive Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Predictive Oncology alpha.
Predictive Oncology Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq | 03/20/2025 |
2 | Acquisition by St. Clair Gregory Sr of 6265 shares of Predictive Oncology subject to Rule 16b-3 | 03/21/2025 |
3 | Predictive Oncology Advances in Drug Repurposing with AI Innovations POAI Stock News | 04/15/2025 |
4 | Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update ... | 05/15/2025 |
5 | Predictive Oncology Inc. Issues Shareholder Letter Titled, Revolutionizing Medicine AI-Driven Biomarker and Drug Discovery for Precision Health | 05/20/2025 |
6 | AI Meets Genomics Predictive Oncology Breakthrough Coincides with Regenerons 256M 23andMe ... | 05/22/2025 |
7 | Predictive Oncology Addresses Legal Dispute with Renovaro POAI Stock News | 05/27/2025 |
8 | Major AI Breakthrough in Cancer Research Leading Pharma Companies Unite in Revolutionary Oncology Initiative - Stock Titan | 06/05/2025 |
9 | Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp | 06/12/2025 |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |